Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC

Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.

CNBC Television • Dec 12, 2025

5 ETFs to Watch as Restrictions on Marijuana Set to Ease

Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.

ETF Trends • Dec 12, 2025

Sell The MJ ETF

Amplify Alternative Harvest ETF has a history of underperformance and recent gains driven by speculative cannabis sector optimism. MJ's portfolio is concentrated in both U.S. MSOs and Canadian LPs, with heavy exposure to stocks currently rated Sell or Strong Sell. Despite recent outperformance versus peers, MJ's index construction and lack of ancillary exposure make it unattractive compared to alternatives like CNBS.

Seeking Alpha • Oct 12, 2025

MJ: Midterms Could Offer Investors Chance To Enjoy High Returns With Cannabis Stocks

Amplify Alternative Harvest ETF is my top cannabis ETF pick due to its diversification and positive response to rescheduling headlines. I expect President Trump to leverage cannabis rescheduling for midterm election gains, which should boost MJ and other cannabis ETFs in the near term. MSOS is downgraded to sell due to high concentration risk, while CNBS is rated a hold because of its reliance on swaps and high expense ratio.

Seeking Alpha • Oct 1, 2025

Disruptive Theme of the Week: Cannabis Staging a Comeback

Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous drug.

ETF Trends • Aug 19, 2025

Rescheduling Should Send MJ And MSOS Sky High

Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. Rescheduling would reduce regulatory and banking risks, potentially unlocking new capital and investor interest, but both ETFs carry high fees and concentration risks. MJ is preferred over MSOS for its greater diversification, though both face challenges from high expense ratios and reliance on swaps.

Seeking Alpha • Aug 13, 2025

Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification

Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the industry, one investing chief said.

CNBC • Aug 11, 2025

MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks

Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ETFs like MJ and MSOS is compelling, making them suitable for risk capital allocations. Demographic trends and bipartisan support suggest federal decriminalization is only a matter of time, further boosting the industry's long-term prospects.

Seeking Alpha • Jun 19, 2025

Are These ETFs Cheap Yet? Crypto, Cannabis, Chips

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers — and maybe even find opportunities.

ETF Trends • Apr 17, 2025

Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS

CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amplify Seymour Cannabis ETF (CNBS) will change its investment policy to invest in securities of U.S. companies engaged in cannabis and hemp-related activities.

GlobeNewsWire • Jan 28, 2025